Viewing Study NCT02728050


Ignite Creation Date: 2025-12-24 @ 5:23 PM
Ignite Modification Date: 2026-02-20 @ 10:44 AM
Study NCT ID: NCT02728050
Status: COMPLETED
Last Update Posted: 2023-07-05
First Post: 2016-03-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor: University of Washington
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Biphenotypic Leukemia View
None Acute Myeloid Leukemia View
None de Novo Myelodysplastic Syndrome View
None Myelodysplastic Syndrome View
None Myeloproliferative Neoplasm View
Keywords: